Autolus director receives option and RSU grants
Autolus Therapeutics plc director Linda Bain received new equity awards as part of her compensation.
Rhea-AI Filing Summary
Autolus Therapeutics plc director Linda Bain received new equity awards as part of her compensation. She was granted a share option covering 47,500 American Depositary Shares with an exercise price of $1.61 per share, expiring on June 29, 2036. These options vest in twelve equal monthly installments starting on July 29, 2026.
She also received 31,667 restricted share units, each representing a contingent right to one American Depositary Share. The RSUs vest in a single installment on June 29, 2027. Each American Depositary Share is convertible at any time into one ordinary share, providing future potential ownership if the awards vest and, for options, are exercised.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Share Units | 31,667 | $0.00 | $0.00 |
| Grant/Award | Share Option (Right to Buy) | 47,500 | $0.00 | $0.00 |
Footnotes (3)
- F1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.
- F2. The RSUs vest in one installment on June 29, 2027.
- F3. Share options vest in twelve equal monthly installments commencing on July 29, 2026.
Key Figures
Key Terms
exercise price financial
FAQ
What equity awards did Autolus (AUTL) director Linda Bain receive?
When do Linda Bain’s new Autolus (AUTL) stock options vest?
What is the exercise price of Linda Bain’s Autolus (AUTL) stock options?
Are Linda Bain’s Autolus (AUTL) equity grants open-market transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.